HS
Highly rated in
8
conditions
Highly rated in
8
conditions
Check Dr. Henning H. Schade's experience treating your condition:
About Dr. Henning H. Schade

Henning Schade is an Internal Medicine expert in Denver, Colorado. Schade has been practicing medicine for over 16 years and is highly rated in 8 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia AML, Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. He is licensed to treat patients in Colorado and South Carolina. Schade is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Henning H. Schade it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Henning H. Schade accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
1721 E 19th Ave, Denver, CO 80218
Background & Education
Graduate Institution
Other, 2006
Specialties
Internal Medicine
Licenses
Internal Medicine in CO
Hospital Affiliations
Presbyterian/St Lukes Medical Center
Childrens Hospital Colorado - Anschutz Medical Campus
Swedish Medical Center
St Vincent Healthcare
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase 1b/2 Study of Selinexor (KPT-330) in Combination With Backbone Treatments for Relapsed/Refractory Multiple Myeloma and Newly Diagnosed Multiple Myeloma
A Phase II Study of Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors